EXACT Sciences Corp.(NASDAQ : EXAS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.90%||63.84||1.0%||$542.01m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.23%||258.59||1.9%||$461.95m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.61%||661.14||2.6%||$422.10m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.93%||2.11||0.7%||$147.50m|
|EXAS||EXACT Sciences Corp.||-1.54%||53.17||17.7%||$147.09m|
|TXG||10X Genomics, Inc.||0.58%||50.16||0.0%||$101.29m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.56%||79.72||4.2%||$98.40m|
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.